Next-generation sequencing (NGS) technologies have become increasingly available for
use in the clinical microbiology diagnostic environment. There are three main applications of …

Streptococcus agalactiae or group B streptococcus (GBS) is a leading cause of serious
neonatal infections. GBS is an opportunistic commensal constituting a part of the intestinal …

Group B Streptococcus (GBS) colonizes the gastrointestinal and vaginal epithelium of a
significant percentage of healthy women, with potential for ascending intrauterine infection …

Group B streptococcus (GBS) causes a high burden of neonatal and infant disease globally.
Implementing a vaccine for pregnant women is a promising strategy to prevent neonatal and …

Streptococcus agalactiae, or group B streptococcus (GBS), is a major neonatal pathogen.
Recent data have elucidated the global prevalence of maternal and neonatal colonization …

Brazilian data for maternal GBS colonization shows different prevalence rates. This
conflicting data may be related to the absence of an official recommendation from the …

Streptococcus agalactiae (group B streptococcus, GBS) is a leading causal organism of
neonatal invasive diseases and severe infections in the elderly. Despite significant …

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is a Gram-positive
bacterium isolated from the vaginal tract of approximately 25% of women. GBS colonization …

Group B Streptococcus, a common commensal in the gut of humans and in the lower genital
tract in women, remains an important cause of neonatal mortality and morbidity. The …

Streptococcus agalactiae (group B streptococcus; GBS) is a colonizer of the gastrointestinal
and urogenital tracts, and an opportunistic pathogen of infants and adults. The worldwide …